Search Medical Condition
Please enter condition
Please choose location from dropdown

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (271) clinical trials

The primary objective for part A of the study is to characterize the safety and pharmacokinetics (PK) of dupilumab administered as a single dose in pediatric patients, 6 months to less than 6 years of age with severe atopic dermatitis (AD). The primary objective for part B of the study ...

Phase

Researchers at the University of Kentucky are inviting you to participate in a study to see if your lung tissue temperature increases when exposed to something you are allergic to such as ragweed, house dust mite, or cat dander.

Phase N/A

The OXFORAD™ Study for Atopic Dermatitis is examining an investigational drug to see how safe and effective it is when given to people like you who have eczema.

Phase N/A

Do you have moderate to severe atopic dermatitis (for at least one year)? A clinical trial designed to evaluate if the trial drug, tralokinumab, can affect the body’s immune responses to vaccines for adult patients with moderate-to-severe atopic dermatitis is currently being conducted. All subjects will receive injections of trial ...

Phase N/A

Dry, Itchy, Red Skin? It may be Eczema! Interested in clinical research on eczema with an experimental oral medication?  

Phase N/A

Local doctors are looking for adults struggling with lupus for clinical research studies of an investigational medication. Doctors are studying this medication to see if it may provide relief with common symptoms associated with lupus.  

Phase N/A

B7451014 is a Phase 3 study to investigate PF-04965842 in patients aged 12 years and over with a minimum body weight of 40 kg who have moderate to severe atopic dermatitis. Subjects responding well to an initial open-label 12 week treatment of PF-04965842 (200 mg) taken orally once daily (QD) ...

Phase

Physical exam and assessments of study condition to be provided at no cost by an experienced provider. No insurance necessary. Compensation will be provided at the end of study participation.  

Phase

This study will be testing an investigational drug for peanut allergies  

Phase

 In this study, you will get either MSTT1041A or placebo.  A placebo looks like a drug but has no active ingredient.   About 90 people will take part in this study. MSTT1041A is an experimental drug, which means that is being tested and is not approved for sale in the United ...

Phase